West Pharmaceutical Services | WST - Debt

Stock Price
233.04
Daily Change
-4.01 -1.69%
Monthly
-16.48%
Yearly
-30.46%
Q1 Forecast
224.00

West Pharmaceutical Services reported $202.7M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Align Technology USD 121.27M 1.75M Sep/2025
Avanos Medical USD 137.3M 29.9M Jun/2025
Baxter International USD 9.73B 584M Jun/2025
Becton, Dickinson and Co. USD 19.18B 160M Sep/2025
Charles River Laboratories USD 2.79B 74.83M Jun/2025
Cooper Companies USD 2.48B 285.1M Jun/2025
Dentsply International USD 2.49B 159M Jun/2025
Haemonetics USD 1.22B 54K Sep/2025
ICU Medical USD 1.39B 148.5M Jun/2025
Insulet USD 1.4B 295.7M Jun/2025
Integra LifeSciences USD 2.01B 170.48M Jun/2025
IQVIA Holdings USD 14.96B 533M Sep/2025
J&J USD 45.8B 4.97B Sep/2025
Medtronic USD 28.61B 93M Jun/2025
Merit Medical Systems USD 820.55M 89.88M Jun/2025
Neogen USD 792.53M 101.58M Jun/2025
Quidel USD 2.79B 378.1M Jun/2025
Repligen USD 533.72M 149.97M Jun/2025
Solventum Corp USD 7.91B 97M Mar/2025
STAAR Surgical USD 40.52M 40.14M Jun/2025
Terumo JPY 174.84B 14.98B Mar/2025
West Pharmaceutical Services USD 202.7M 100K Sep/2025